© 2003 by Oxford University Press
© 2003 Oxford University Press
BRIEF COMMUNICATION |
Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals
Affiliations of authors: E. Giovannucci, E. B. Rimm, M. J. Stampfer, W. C. Willett, Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, and Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA; Y. Liu, K. Wu, Department of Nutrition, Harvard School of Public Health; M. Leitzmann, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
Correspondence to: Edward Giovannucci, MD, ScD, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115 (e-mail: edward. giovannucci{at}channing.harvard.edu).
ABSTRACT
The relationship between body mass index (BMI) and prostate cancer risk may be complex because obesity is associated with various hormonal factors and because the influence of BMI may differ according to whether the cancers are hereditary or sporadic. We used data from the Health Professionals Follow-Up Study, in which 2896 incident cases of prostate cancer were reported from February 1, 1986, through January 31, 2000, to determine prospectively whether BMI was associated with the risk of hereditary (men <60 years of age or with a positive family history of prostate cancer) and sporadic (men 
60 years of age and without such a family history) prostate cancer. The risk of prostate cancer in men with a higher BMI (30 kg/m2) was lower than that in men with a lower BMI (23–24.9 kg/m2) but only if they were younger (<60 years old) (relative risk = 0.52, 95% confidence interval = 0.33 to 0.83; Ptrend<.001) or had a family history of prostate cancer (relative risk = 0.74, 95% confidence interval = 0.45 to 1.19; Ptrend = .01). However, for groups with more sporadic cancers, BMI had a weak, non–statistically significant positive association with prostate cancer. We observed statistically significant interactions between BMI and age (Pinteraction<.001, two-sided Wald test) and between BMI and family history of prostate cancer (Pinteraction = .006, two-sided Wald test). Patterns for BMI and waist circumference were similar. Because obesity is associated with lower circulating concentrations of testosterone, our results suggest the hypothesis that androgens may play a more direct role for early-onset or hereditary prostate cancers than for sporadic prostate cancers.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Rundle, C. Richards, and A. I. Neugut Body Composition, Abdominal Fat Distribution, and Prostate-Specific Antigen Test Results Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Pischon, H. Boeing, S. Weikert, N. Allen, T. Key, N. F. Johnsen, A. Tjonneland, M. T. Severinsen, K. Overvad, S. Rohrmann, et al. Body Size and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3252 - 3261. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Chen, E. Giovannucci, P. Kraft, and D. J.Hunter Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study Carcinogenesis, May 1, 2008; 29(5): 999 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-i. Hisasue, M. Yanase, T. Shindo, H. Iwaki, F. Fukuta, S. Nishida, T. Muranaka, S. Miyamoto, T. Tsukamoto, and K. Takatsuka Influence of Body Mass Index and Total Testosterone Level on Biochemical Recurrence Following Radical Prostatectomy Jpn. J. Clin. Oncol., February 14, 2008; (2008) hym162v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Banez, R. J. Hamilton, A. W. Partin, R. T. Vollmer, L. Sun, C. Rodriguez, Y. Wang, M. K. Terris, W. J. Aronson, J. C. Presti Jr, et al. Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer JAMA, November 21, 2007; 298(19): 2275 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Chen, E. Giovannucci, P. Kraft, R. Lazarus, and D. J. Hunter Association between Toll-Like Receptor Gene Cluster (TLR6, TLR1, and TLR10) and Prostate Cancer Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 1982 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W Hsing, L. C Sakoda, and S. C Chua Jr Obesity, metabolic syndrome, and prostate cancer Am. J. Clinical Nutrition, September 1, 2007; 86(3): 843S - 857S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Slattery, M. Schumacher, A. Lanier, S Edwards, R Edwards, M. Murtaugh, J Sandidge, G. Day, D Kaufman, S Kanekar, et al. A Prospective Cohort of American Indian and Alaska Native People: Study Design, Methods, and Implementation Am. J. Epidemiol., September 1, 2007; 166(5): 606 - 615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Nagata, T. Sonoda, M. Mori, N. Miyanaga, K. Okumura, K. Goto, S. Naito, K. Fujimoto, Y. Hirao, A. Takahashi, et al. Dietary Isoflavones May Protect against Prostate Cancer in Japanese Men J. Nutr., August 1, 2007; 137(8): 1974 - 1979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Littman, E. White, and A. R. Kristal Anthropometrics and Prostate Cancer Risk Am. J. Epidemiol., June 1, 2007; 165(11): 1271 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland and E. A. Platz Obesity and Prostate Cancer: Making Sense out of Apparently Conflicting Data Epidemiol. Rev., May 3, 2007; (2007) mxm006v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Mukamal, I. Kawachi, M. Miller, and E. B. Rimm Body Mass Index and Risk of Suicide Among Men Arch Intern Med, March 12, 2007; 167(5): 468 - 475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Tuohimaa, L. Tenkanen, H. Syvala, S. Lumme, T. Hakulinen, J. Dillner, and M. Hakama Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2007; 16(2): 302 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Werny, T. Thompson, M. Saraiya, D. Freedman, B. J. Kottiri, R. R. German, and M. Wener Obesity Is Negatively Associated with Prostate-Specific Antigen in U.S. Men, 2001-2004 Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 70 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rodriguez, S. J. Freedland, A. Deka, E. J. Jacobs, M. L. McCullough, A. V. Patel, M. J. Thun, and E. E. Calle Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 63 - 69. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lund Haheim, T. F. Wisloff, I. Holme, and P. Nafstad Metabolic Syndrome Predicts Prostate Cancer in a Cohort of Middle-aged Norwegian Men Followed for 27 Years Am. J. Epidemiol., October 15, 2006; 164(8): 769 - 774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Gong, M. L. Neuhouser, P. J. Goodman, D. Albanes, C. Chi, A. W. Hsing, S. M. Lippman, E. A. Platz, M. N. Pollak, I. M. Thompson, et al. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1977 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Lockett, M.C. Hall, P. E. Clark, S.-C. Chuang, B. Robinson, H.-Y. Lin, L.J. Su, and J. J. Hu DNA damage levels in prostate cancer cases and controls Carcinogenesis, June 1, 2006; 27(6): 1187 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Chen, E. Giovannucci, R. Lazarus, P. Kraft, S. Ketkar, and D. J. Hunter Sequence Variants of Toll-Like Receptor 4 and Susceptibility to Prostate Cancer Cancer Res., December 15, 2005; 65(24): 11771 - 11778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Cooperberg, J. W. Moul, and P. R. Carroll The Changing Face of Prostate Cancer J. Clin. Oncol., November 10, 2005; 23(32): 8146 - 8151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Parsons, H. B. Carter, E. A. Platz, E. J. Wright, P. Landis, and E. J. Metter Serum Testosterone and the Risk of Prostate Cancer: Potential Implications for Testosterone Therapy Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2257 - 2260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Panagiotakos, C. Pitsavos, E. Polychronopoulos, C. Chrysohoou, A. Menotti, A. Dontas, and C. Stefanadis Total Cholesterol and Body Mass Index in Relation to 40-Year Cancer Mortality (The Corfu Cohort of the Seven Countries Study) Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1797 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Giovannucci, Y. Liu, M. F. Leitzmann, M. J. Stampfer, and W. C. Willett A Prospective Study of Physical Activity and Incident and Fatal Prostate Cancer Arch Intern Med, May 9, 2005; 165(9): 1005 - 1010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Platz, M. F. Leitzmann, N. Rifai, P. W. Kantoff, Y.-C. Chen, M. J. Stampfer, W. C. Willett, and E. Giovannucci Sex Steroid Hormones and the Androgen Receptor Gene CAG Repeat and Subsequent Risk of Prostate Cancer in the Prostate-Specific Antigen Era Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1262 - 1269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Freedland, W. B. Isaacs, L. A. Mangold, S. K. Yiu, K. A. Grubb, A. W. Partin, J. I. Epstein, P. C. Walsh, and E. A. Platz Stronger Association between Obesity and Biochemical Progression after Radical Prostatectomy among Men Treated in the Last 10 Years Clin. Cancer Res., April 15, 2005; 11(8): 2883 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Platz, M. F. Leitzmann, D. S. Michaud, W. C. Willett, and E. Giovannucci Interrelation of Energy Intake, Body Size, and Physical Activity with Prostate Cancer in a Large Prospective Cohort Study Cancer Res., December 1, 2003; 63(23): 8542 - 8548. [Abstract] [Full Text] [PDF]
|
|